Processa Pharmaceuticals, Inc.

Contributing Author

Recent Articles by Processa Pharmaceuticals, Inc.

Nov-05	Processa Pharmaceuticals Announces Poster Presentation of Adaptive Phase 2/3 PCS499 Study in FSGS at ASN Kidney Week 2025 PCSA GlobeNewswire
Aug-07	Processa Pharmaceuticals Secures Strategic Investment and Evaluates Corporate Crypto Treasury Strategies PCSA GlobeNewswire
Jul-01	Processa Pharmaceuticals Provides Portfolio and Business Update PCSA GlobeNewswire
Jun-17	Processa Pharmaceuticals Announces Pricing of $7 Million Public Offering PCSA GlobeNewswire
Jun-17	Processa Pharmaceuticals Signs Binding Term Sheet Granting Intact Therapeutics Exclusive Option to License Phase 2 Gastroparesis Drug Candidate PCSA GlobeNewswire
Jun-13	Processa Pharmaceuticals to Engage Potential Partners and Investors at BIO International Convention 2025 PCSA GlobeNewswire
May-30	Processa Pharmaceuticals Announces Presentation and Publication of Three Abstracts at 2025 ASCO Annual Meeting PCSA GlobeNewswire